Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats
Open Access
- 1 January 2011
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Systems Neuroscience
- Vol. 5, 40
Abstract
Inhibitors of neuronal and endothelial nitric oxide synthase decrease l-3,4-dihidroxifenilalanine (L-DOPA)-induced dyskinesias in rodents. The mechanism of nitric oxide inhibitor action is unknown. The aims of the present study were to investigate the decrease of L-DOPA-induced abnormal involuntary movements (AIMs) in 6-hydroxydopamine (6-OHDA)-lesioned rats by nitric oxide inhibitors following either acute or chronic treatment. The primary findings of this study were that NG-nitro-L-Arginine, an inhibitor of endothelial and neuronal nitric oxide synthase, attenuated AIMs induced by chronic and acute L-DOPA. In contrast, rotational behavior was attenuated only after chronic L-DOPA. The 6-OHDA lesion and the L-DOPA treatment induced a bilateral increase (1.5 times) in the neuronal nitric oxide synthase (nNOS) protein and nNOS mRNA in the striatum and in the frontal cortex. There was a parallel increase, bilaterally, of the FosB/ΔFosB, primarily in the ipsilateral striatum. The exception was in the contralateral striatum and the ipsilateral frontal cortex, where chronic L-DOPA treatment induced an increase of approximately 10 times the nNOS mRNA. Our results provided further evidence of an anti-dyskinetic effect of NOS inhibitor. The effect appeared under L-DOPA acute and chronic treatment. The L-DOPA treatment also revealed an over-expression of the neuronal NOS in the frontal cortex and striatum. Our results corroborated findings that L-DOPA-induced rotation differs between acute and chronic treatment. The effect of the NOS inhibitor conceivably relied on the L-DOPA structural modifications in the Parkinsonian brain. Taken together, these data provided a rationale for further evaluation of NOS inhibitors in the treatment of L-DOPA-induced dyskinesia.Keywords
This publication has 74 references indexed in Scilit:
- Neurotransmission in Parkinson’s disease: beyond dopamineEuropean Journal of Neurology, 2010
- Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's diseaseNeurobiology of Disease, 2008
- In vivo electrophysiology of dopamine‐denervated striatum: Focus on the nitric oxide/cGMP signaling pathwaySynapse, 2008
- Nitric oxide synthase regulation and diversity: Implications in Parkinson’s diseaseNitric Oxide, 2006
- Nitric oxide and neurological disordersMolecular Aspects of Medicine, 2005
- Recent developments in the pharmacological treatment of Parkinson’s diseaseExpert Opinion on Investigational Drugs, 2003
- Behavioral and Anatomical Effects of Long-Term ?-Dihydroxyphenylalanine (L-DOPA) Administration in Rats with Unilateral Lesions of the Nigrostriatal SystemExperimental Neurology, 2002
- Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genesGenome Biology, 2002
- Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's diseaseEuropean Journal of Neuroscience, 2002
- Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping testThe Journal of Neuroscience, 1995